Sales decline 31.61% to Rs 10.86 crore
Net profit of Bafna Pharmaceuticals reported to Rs 28.09 crore in the quarter ended December 2017 as against net loss of Rs 3.44 crore during the previous quarter ended December 2016. Sales declined 31.61% to Rs 10.86 crore in the quarter ended December 2017 as against Rs 15.88 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales10.8615.88 -32 OPM %5.06-0.76 -PBDT29.08-2.47 LP PBT28.09-3.49 LP NP28.09-3.44 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
